Logo image
Integration of Cognitive-Behavioral Therapy and Pharmacotherapy in the Treatment of Insomnia
Journal article   Peer reviewed

Integration of Cognitive-Behavioral Therapy and Pharmacotherapy in the Treatment of Insomnia

Donna M. Sudak, Jacqueline Kloss and Jessica Zamzow
International journal of cognitive therapy, v 7(2), pp 162-174
01 Jun 2014

Abstract

Life Sciences & Biomedicine Psychiatry Psychology Psychology, Clinical Science & Technology Social Sciences
Insomnia is a widespread public health concern that can present alone or in the context of other psychiatric and medical conditions. Both cognitive-behavioral therapy for insomnia (CBT-I) and pharmacotherapy, including benzodiazepines (BZs) and benzodiazepine-receptor antagonists (BZRAs), are efficacious for the treatment of insomnia. Hypnotics and CBT-I each offer different long-and short-term advantages and disadvantages. Recent research examining the efficacy of combining CBT-I and hypnotic therapies aim to capitalize on the relative benefits of each form of treatment. In this article we synthesize relevant empirical evidence for the efficacy of hypnotics and CBT-I when used as independent therapies; the advantages and disadvantages of using combined approaches to treat insomnia; and the use of combined treatment among older adults and patients with psychiatric comorbidities. Optimal delivery methods for combined treatments (e. g., best sequencing and combination protocols) have been investigated, but require further research in order to inform clear practice guidelines.

Metrics

3 Record Views
1 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Psychiatry
Psychology, Clinical
Logo image